Circulars
Pharmacy Circular 007-26 Levemir Discontinuation
Published: January 2026
Updated: March 2026
Documents
Pharmacy Circular 007-26 Levemir Discontinuation
PDF, 394KB, 5 pages
Summary
Pharmacy Circular 007-26 on Levemir Discontinuation informs pharmacists that Novo Nordisk is discontinuing Levemir® (insulin detemir) with Irish supply expected to cease by the end of 2026 and advises planning for patients to be switched to alternative basal insulins.
This is a beta version - your feedback will help us to improve it